Novel Stimuli-Responsive Pectin-PVP-Functionalized Clay Based Smart Hydrogels for Drug Delivery and Controlled Release Application

Stimuli-responsive drug delivery systems are urgently required for injectable site-specific delivery and release of drugs in a controlled manner. For this purpose, we developed novel pH-sensitive, biodegradable, and antimicrobial hydrogels from bio-macromolecule pectin, polyvinylpyrrolidone (PVP), 3-aminopropyl (diethoxy)methyl silane (3-APDEMS), and sepiolite clay via blending and solution casting technique. The purified sepiolite (40 um) was functionalized with 3-APDEMS crosslinker (ex-situ modification) followed by hydrogels fabrication. FTIR and SEM confirmed crosslinked structural integrity and rod-like morphology of hydrogels respectively. The swelling properties of hydrogels could be controlled by varying the concentration of modified clay in pectin/PVP blends. Moreover, the decrease in pH increased the swelling of hydrogels indicating the pH-responsiveness of hydrogels. All hydrogels were degraded after 21 days in phosphate buffer saline pH 7.4 (human blood pH). In-vitro cytotoxicity against 3T3 mouse fibroblast cell line analysis confirmed cytocompatibility of all hydrogels. Ceftriaxone sodium (CTX-S) was selected as a model drug. The release profile of the hydrogel showed 91.82% release in PBS for 2 h in a consistent and controlled manner. The chemical structure of the drug remained intact during and after release confirmed through UV-Visible spectroscopy. Overall, these hydrogels could be used as potential scaffolds for future biomedical applications

Mortality from gastrointestinal congenital anomalies at 264 hospitals in 74 low-income, middle-income, and high-income countries: a multicentre, international, prospective cohort study

Summary Background Congenital anomalies are the fifth leading cause of mortality in children younger than 5 years globally. Many gastrointestinal congenital anomalies are fatal without timely access to neonatal surgical care, but few studies have been done on these conditions in low-income and middle-income countries (LMICs). We compared outcomes of the seven most common gastrointestinal congenital anomalies in low-income, middle-income, and high-income countries globally, and identified factors associated with mortality. Methods We did a multicentre, international prospective cohort study of patients younger than 16 years, presenting to hospital for the first time with oesophageal atresia, congenital diaphragmatic hernia, intestinal atresia, gastroschisis, exomphalos, anorectal malformation, and Hirschsprung’s disease. Recruitment was of consecutive patients for a minimum of 1 month between October, 2018, and April, 2019. We collected data on patient demographics, clinical status, interventions, and outcomes using the REDCap platform. Patients were followed up for 30 days after primary intervention, or 30 days after admission if they did not receive an intervention. The primary outcome was all-cause, in-hospital mortality for all conditions combined and each condition individually, stratified by country income status. We did a complete case analysis. Findings We included 3849 patients with 3975 study conditions (560 with oesophageal atresia, 448 with congenital diaphragmatic hernia, 681 with intestinal atresia, 453 with gastroschisis, 325 with exomphalos, 991 with anorectal malformation, and 517 with Hirschsprung’s disease) from 264 hospitals (89 in high-income countries, 166 in middleincome countries, and nine in low-income countries) in 74 countries. Of the 3849 patients, 2231 (58·0%) were male. Median gestational age at birth was 38 weeks (IQR 36–39) and median bodyweight at presentation was 2·8 kg (2·3–3·3). Mortality among all patients was 37 (39·8%) of 93 in low-income countries, 583 (20·4%) of 2860 in middle-income countries, and 50 (5·6%) of 896 in high-income countries (p<0·0001 between all country income groups). Gastroschisis had the greatest difference in mortality between country income strata (nine [90·0%] of ten in lowincome countries, 97 [31·9%] of 304 in middle-income countries, and two [1·4%] of 139 in high-income countries; p≤0·0001 between all country income groups). Factors significantly associated with higher mortality for all patients combined included country income status (low-income vs high-income countries, risk ratio 2·78 [95% CI 1·88–4·11], p<0·0001; middle-income vs high-income countries, 2·11 [1·59–2·79], p<0·0001), sepsis at presentation (1·20 [1·04–1·40], p=0·016), higher American Society of Anesthesiologists (ASA) score at primary intervention (ASA 4–5 vs ASA 1–2, 1·82 [1·40–2·35], p<0·0001; ASA 3 vs ASA 1–2, 1·58, [1·30–1·92], p<0·0001]), surgical safety checklist not used (1·39 [1·02–1·90], p=0·035), and ventilation or parenteral nutrition unavailable when needed (ventilation 1·96, [1·41–2·71], p=0·0001; parenteral nutrition 1·35, [1·05–1·74], p=0·018). Administration of parenteral nutrition (0·61, [0·47–0·79], p=0·0002) and use of a peripherally inserted central catheter (0·65 [0·50–0·86], p=0·0024) or percutaneous central line (0·69 [0·48–1·00], p=0·049) were associated with lower mortality. Interpretation Unacceptable differences in mortality exist for gastrointestinal congenital anomalies between lowincome, middle-income, and high-income countries. Improving access to quality neonatal surgical care in LMICs will be vital to achieve Sustainable Development Goal 3.2 of ending preventable deaths in neonates and children younger than 5 years by 2030

Prevalence of Depression in Animal Model of High Fat Diet Induced Obesity

The prevalence of obesity is substantially increased in developing countries and it is considerably associated with type 2 diabetes (T2DM), dyslipidemia, and hypertension. These symptoms are clustered to form metabolic syndrome. In accordance with the Researchers opinion, obese people are more likely to suffer from depression, a mental affliction that appears due to chronic stress, disturbs thoughts, behavior, and feelings. It has been addressed that the physiological impairments which are undergoing due to obesity can affect the metabolic activities which in turn give impact on brain and affect it’s functioning, because obesity itself seems to constitute a chronic stressful state thus, exacerbates the risk of depression. Present study intended to illuminate the anticipated links between obesity and stress. To make possible the study, animal model of obesity was accomplished by subjecting the Albino wistar rats with energy-dense diet (high fat diet) for 5 weeks; later on, chronic mild stress paradigm was implemented along with high fat feeding for 2 weeks. As expected, high fat feeding increased the adiposity in rodents. Obese animals presented the depressive symptoms more prominent than normal fat feeding rats. Present findings suggest that obesity could increase the depressive symptoms potentially involve in the recruitment of depression

Prevalence of Depression in Animal Model of High Fat Diet Induced Obesity

The prevalence of obesity is substantially increased in developing countries and it is considerably associated with type 2 diabetes (T2DM), dyslipidemia, and hypertension. These symptoms are clustered to form metabolic syndrome. In accordance with the Researchers opinion, obese people are more likely to suffer from depression, a mental affliction that appears due to chronic stress, disturbs thoughts, behavior, and feelings. It has been addressed that the physiological impairments which are undergoing due to obesity can affect the metabolic activities which in turn give impact on brain and affect it’s functioning, because obesity itself seems to constitute a chronic stressful state thus, exacerbates the risk of depression. Present study intended to illuminate the anticipated links between obesity and stress. To make possible the study, animal model of obesity was accomplished by subjecting the Albino wistar rats with energy-dense diet (high fat diet) for 5 weeks; later on, chronic mild stress paradigm was implemented along with high fat feeding for 2 weeks. As expected, high fat feeding increased the adiposity in rodents. Obese animals presented the depressive symptoms more prominent than normal fat feeding rats. Present findings suggest that obesity could increase the depressive symptoms potentially involve in the recruitment of depression

Dapoxetine Treatment Leads to Attenuation of Chronic Unpredictable Stress Induced Behavioral Deficits in Rats Model of Depression

Stressful conditions possess a complex relationship with brain and body’s reaction to stress and beginning of depression. The hypofunctioning of Serotonin (5-Hydroxytryptamine; 5-HT) is known to be established in unpredictable chronic mild stress exposure. UCMS is broadly taken as the most promising and favorable model to study depression in various animals, imitating many human depressive symptoms. With the class of selective serotonin [5-hydroxytryptamine (5-HT)] reuptake inhibitors (SSRIs) is now considered as the most prescribed antidepressant that can reverse petrochemical and behavioral effects of stresses. The aim of the present study was to investigate whether repeated administration of dapoxetine at dose 1.0 mg/kg could reversed the behavioral deficits induced by UCMS in rat model of depression. Rats exposed to UCMS revealed a significant reduction in food intake as well as growth rate. Locomotive activity in home cage and anxiolytic behavior in light/dark activity box were greater in animals of unstressed group as compared to animals of stressed group. The mechanism involved in the inhibition of serotonin reuptake at pre-synaptic receptors by repeated dapoxetine administration is discussed. The knowledge accumulated may facilitate an innovative approach for extending the therapeutic use of dapoxetine and the interaction between stress and behavioral functions

Upregulation of Nrf2 in myocardial infarction and ischemia-reperfusion injury of the heart

Myocardial infarction (MI) is a leading cause of morbidity and mortality in the world and is characterized by ischemic necrosis of an area of the myocardium permanently devoid of blood supply. During reperfusion, reactive oxygen species are released and this causes further insult to the myocardium, resulting in ischemia-reperfusion (IR) injury. Since Nrf2 is a key regulator of redox balance, it is essential to determine its contribution to these two disease processes. Conventionally Nrf2 levels have been shown to rise immediately after ischemia and reperfusion but its contribution to disease process a week after the injury remains uncertain. Mice were divided into MI, IR injury, and sham surgery groups and were sacrificed 1 week after surgery. Infarct was visualized using H&E and trichrome staining and expression of Nrf2 was assessed using immunohistochemistry, Western blot, and ELISA. MI displayed a higher infarct size than the IR group (MI: 31.02 ± 1.45%, IR: 13.03 ± 2.57%; p \u3c 0.01). We observed a significantly higher expression of Nrf2 in the MI group compared to the IR model using immunohistochemistry, spot densitometry of Western blot (MI: 2.22 ± 0.16, IR: 1.81 ± 0.10, Sham: 1.52 ± 0.13; p = 0.001) and ELISA (MI: 80.78 ± 27.08, IR: 31.97 ± 4.35; p \u3c 0.01). There is a significantly higher expression of Nrf2 in MI compared to the IR injury group. Modulation of Nrf2 could be a potential target for therapeutics in the future, and its role in cardioprotection can be further investigated

S1 Data -

Myocardial infarction (MI) is a leading cause of morbidity and mortality in the world and is characterized by ischemic necrosis of an area of the myocardium permanently devoid of blood supply. During reperfusion, reactive oxygen species are released and this causes further insult to the myocardium, resulting in ischemia-reperfusion (IR) injury. Since Nrf2 is a key regulator of redox balance, it is essential to determine its contribution to these two disease processes. Conventionally Nrf2 levels have been shown to rise immediately after ischemia and reperfusion but its contribution to disease process a week after the injury remains uncertain. Mice were divided into MI, IR injury, and sham surgery groups and were sacrificed 1 week after surgery. Infarct was visualized using H&E and trichrome staining and expression of Nrf2 was assessed using immunohistochemistry, Western blot, and ELISA. MI displayed a higher infarct size than the IR group (MI: 31.02 ± 1.45%, IR: 13.03 ± 2.57%; p </div

S1 Raw images -

Myocardial infarction (MI) is a leading cause of morbidity and mortality in the world and is characterized by ischemic necrosis of an area of the myocardium permanently devoid of blood supply. During reperfusion, reactive oxygen species are released and this causes further insult to the myocardium, resulting in ischemia-reperfusion (IR) injury. Since Nrf2 is a key regulator of redox balance, it is essential to determine its contribution to these two disease processes. Conventionally Nrf2 levels have been shown to rise immediately after ischemia and reperfusion but its contribution to disease process a week after the injury remains uncertain. Mice were divided into MI, IR injury, and sham surgery groups and were sacrificed 1 week after surgery. Infarct was visualized using H&E and trichrome staining and expression of Nrf2 was assessed using immunohistochemistry, Western blot, and ELISA. MI displayed a higher infarct size than the IR group (MI: 31.02 ± 1.45%, IR: 13.03 ± 2.57%; p </div

ELISA of Nrf2 demonstrating a higher expression in the MI group.

*p = 0.001(versus sham), #p = 0.001 (MI versus IR).</p